Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PYY Polyclonal Antibody, APC-Cy5.5 Conjugated

Product Specifications

Background

This gut peptide inhibits exocrine pancreatic secretion, has a vasoconstrictory action and inhibitis jejunal and colonic mobility.

Synonyms

PYY1; PYY-I; Peptide YY; PYY; Peptide tyrosine tyrosine

Gene ID

5697

Swiss Prot

P10082

Cellular Locus

Secreted

Host

Rabbit

Immunogen

29-64/97

Target

PYY

Clonality

Polyclonal

Isotype

IgG

Conjugation

APC-Cy5.5

Source

KLH conjugated synthetic peptide human Peptide YY/PYY

Applications

IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

650nm/694nm

Concentration

1µg/µl

Dilution

IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Gene ID URL

5697

Predicted Cross Reactivity

Human

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)
RA0137-01 100 µg

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)

Ask
View Details
Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)
RA0137-02 1 mg

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)

Ask
View Details
Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)
RA0137-03 5 mg

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)

Ask
View Details
Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)
RA0137-04 10 mg

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)

Ask
View Details
Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)
RA0137-05 25 mg

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)

Ask
View Details
Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)
RA0137-06 50 mg

Cergutuzumab (Biosimilar Reference Antibody) (CEACAM5)

Ask
View Details